• Energy Research
• Neuroinformatics close

AbstractNon‐adaptive activation of dopamine transmission in the nucleus accumbens shell by drugs of abuse has been attributed a fundamental role in the mechanism of drug addiction. In order to test this hypothesis, we compared in the same subject the effect of an addictive drug (ethanol) and of taste stimuli, including ethanol's own taste, on dialysate dopamine in the nucleus accumbens shell as an estimate of dopamine transmission and on taste reactivity as an expression of motivational valence. Ethanol was also monitored in the dialysates. In naive rats, intraoral infusion of a 20% sucrose + chocolate solution elicited a monophasic increase of dialysate dopamine immediately after the intraoral infusion. In contrast, intraoral infusion of 10% ethanol, 10% ethanol + 20% sucrose or 10% ethanol + 20% sucrose + chocolate solutions elicited a biphasic increase of nucleus accumbens dopamine with an early taste‐related rise and a late rise related to dialysate ethanol. Pre‐exposure to the ethanol solutions 24 h before resulted in the absence of the early dopamine rise and permanence of the late dopamine rise. This late dopamine rise was actually increased as compared with that of the nonpre‐exposed group when sucrose‐containing ethanol solutions were tested. The results indicate that single trial pre‐exposure to the ethanol solutions differentially affects the responsiveness of nucleus accumbens shell dopamine to the direct intracerebral action of ethanol and to the effect of its taste with potentiation, or no change of the first and abolition of the second. These observations point to the existence of major differences in the adaptive regulation of nucleus accumbens dopamine transmission in the shell after drug as compared with taste reward. These differences, in turn, are consistent with a role of nucleus accumbens shell dopamine in the mechanism of the behavioural effects of addictive drugs.

AbstractNon‐adaptive activation of dopamine transmission in the nucleus accumbens shell by drugs of abuse has been attributed a fundamental role in the mechanism of drug addiction. In order to test this hypothesis, we compared in the same subject the effect of an addictive drug (ethanol) and of taste stimuli, including ethanol's own taste, on dialysate dopamine in the nucleus accumbens shell as an estimate of dopamine transmission and on taste reactivity as an expression of motivational valence. Ethanol was also monitored in the dialysates. In naive rats, intraoral infusion of a 20% sucrose + chocolate solution elicited a monophasic increase of dialysate dopamine immediately after the intraoral infusion. In contrast, intraoral infusion of 10% ethanol, 10% ethanol + 20% sucrose or 10% ethanol + 20% sucrose + chocolate solutions elicited a biphasic increase of nucleus accumbens dopamine with an early taste‐related rise and a late rise related to dialysate ethanol. Pre‐exposure to the ethanol solutions 24 h before resulted in the absence of the early dopamine rise and permanence of the late dopamine rise. This late dopamine rise was actually increased as compared with that of the nonpre‐exposed group when sucrose‐containing ethanol solutions were tested. The results indicate that single trial pre‐exposure to the ethanol solutions differentially affects the responsiveness of nucleus accumbens shell dopamine to the direct intracerebral action of ethanol and to the effect of its taste with potentiation, or no change of the first and abolition of the second. These observations point to the existence of major differences in the adaptive regulation of nucleus accumbens dopamine transmission in the shell after drug as compared with taste reward. These differences, in turn, are consistent with a role of nucleus accumbens shell dopamine in the mechanism of the behavioural effects of addictive drugs.

Platelet aggregation, secretion of serotonin, and formation of thromboxane B2 induced by platelet-activating factor (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) were studied in plasma containing physiological concentrations of ionized calcium in eight alcoholics after cessation of heavy drinking. Responses of platelets of four nonalcoholic volunteers, matched with a subgroup of the alcoholics by age and sex, were also investigated. Aggregation of platelets from alcoholics was significantly less throughout the 6-day detoxification period compared with controls. Secretion of serotonin (5-hydroxy-tryptamine) was negligible and the production of thromboxane B2 was not detectable. Decreased platelet aggregability in response to aggregating agents, including platelet-activating factor, may be important in the development of hemorrhagic complications in alcoholics.

Platelet aggregation, secretion of serotonin, and formation of thromboxane B2 induced by platelet-activating factor (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) were studied in plasma containing physiological concentrations of ionized calcium in eight alcoholics after cessation of heavy drinking. Responses of platelets of four nonalcoholic volunteers, matched with a subgroup of the alcoholics by age and sex, were also investigated. Aggregation of platelets from alcoholics was significantly less throughout the 6-day detoxification period compared with controls. Secretion of serotonin (5-hydroxy-tryptamine) was negligible and the production of thromboxane B2 was not detectable. Decreased platelet aggregability in response to aggregating agents, including platelet-activating factor, may be important in the development of hemorrhagic complications in alcoholics.

BackgroundVentral tegmental area (VTA) GABA neurons have been heavily implicated in alcohol reinforcement and reward. In animals that self‐administer alcohol, VTA GABA neurons exhibit increased excitability that may contribute to alcohol's rewarding effects. The present study investigated the effects of acute and chronic ethanol exposure on glutamate (GLU) synaptic transmission to VTA GABA neurons.MethodsWhole‐cell recordings of evoked, spontaneous, and miniature excitatory postsynaptic currents (eEPSCs, sEPSCs, and mEPSCs, respectively) were performed on identified GABA neurons in the VTA of GAD67‐GFP+ transgenic mice. Three ethanol exposure paradigms were used: acute ethanol superfusion; a single ethanol injection; and chronic vapor exposure.ResultsAcute ethanol superfusion increased the frequency of EPSCs but inhibited mEPSC frequency and amplitude. During withdrawal from a single injection of ethanol, the frequency of sEPSCs was lower than saline controls. There was no difference in α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA)/N‐methyl‐d‐aspartate (NMDA) ratio between neurons following withdrawal from a single exposure to ethanol. However, following withdrawal from chronic ethanol, sEPSCs and mEPSCs had a greater frequency than air controls. There was no difference in AMPA/NMDA ratio following chronic ethanol.ConclusionsThese results suggest that presynaptic mechanisms involving local circuit GLU neurons, and not GLU receptors, contribute to adaptations in VTA GABA neuron excitability that accrue to ethanol exposure, which may contribute to the rewarding properties of alcohol via their regulation of mesolimbic dopamine transmission.

BackgroundVentral tegmental area (VTA) GABA neurons have been heavily implicated in alcohol reinforcement and reward. In animals that self‐administer alcohol, VTA GABA neurons exhibit increased excitability that may contribute to alcohol's rewarding effects. The present study investigated the effects of acute and chronic ethanol exposure on glutamate (GLU) synaptic transmission to VTA GABA neurons.MethodsWhole‐cell recordings of evoked, spontaneous, and miniature excitatory postsynaptic currents (eEPSCs, sEPSCs, and mEPSCs, respectively) were performed on identified GABA neurons in the VTA of GAD67‐GFP+ transgenic mice. Three ethanol exposure paradigms were used: acute ethanol superfusion; a single ethanol injection; and chronic vapor exposure.ResultsAcute ethanol superfusion increased the frequency of EPSCs but inhibited mEPSC frequency and amplitude. During withdrawal from a single injection of ethanol, the frequency of sEPSCs was lower than saline controls. There was no difference in α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA)/N‐methyl‐d‐aspartate (NMDA) ratio between neurons following withdrawal from a single exposure to ethanol. However, following withdrawal from chronic ethanol, sEPSCs and mEPSCs had a greater frequency than air controls. There was no difference in AMPA/NMDA ratio following chronic ethanol.ConclusionsThese results suggest that presynaptic mechanisms involving local circuit GLU neurons, and not GLU receptors, contribute to adaptations in VTA GABA neuron excitability that accrue to ethanol exposure, which may contribute to the rewarding properties of alcohol via their regulation of mesolimbic dopamine transmission.

The effect of ethanol in vitro on inositol lipid metabolism in brain slices was investigated under nonstimulating and stimulating conditions. In cerebral cortical slices 100 microM norepinephrie (NE), 1 mM carbachol, 100 microM serotonin, 20 mM KCl, 1 mM glutamate and 30 microM A23187 stimulated inositide hydrolysis as measured by the release of [3H]inositol phosphates from [3H]myoinositol labeled slices. Ethanol (500 mM) inhibited nonstimulated inositide hydrolysis but had variable effects on stimulated inositide breakdown. NE-, KCl- and glutamate-stimulated [3H]inositol phosphate release was inhibited by 500 mM ethanol in the cortex. The inhibitory effect of ethanol on NE-stimulated inositide hydrolysis was concentration dependent and significant at concentrations as low as 100 mM. Inhibition by ethanol appeared to be noncompetitive. A similar pattern of inhibition by ethanol was observed when KCl was the stimulant. In hippocampal and hypothalamic slices, similar to cortical slices. NE- and KCl-stimulated inositide breakdown was significantly inhibited by ethanol. However, in brain stem slices, only KCl-stimulated [3H]inositol phosphate release was inhibited. Striatal slices stimulated by carbachol, NE and KCl were sensitive to the inhibitory effects of ethanol on inositol lipid breakdown. These results suggest that ethanol in vitro has specific effects on inositol lipid metabolism depending on the brain region studied and the type of stimulation. Moreover, the differential sensitivity to ethanol of stimulated inositide hydrolysis in the brain may contribute, at least in part, to some of the pharmacological effects of ethanol in vivo.

The effect of ethanol in vitro on inositol lipid metabolism in brain slices was investigated under nonstimulating and stimulating conditions. In cerebral cortical slices 100 microM norepinephrie (NE), 1 mM carbachol, 100 microM serotonin, 20 mM KCl, 1 mM glutamate and 30 microM A23187 stimulated inositide hydrolysis as measured by the release of [3H]inositol phosphates from [3H]myoinositol labeled slices. Ethanol (500 mM) inhibited nonstimulated inositide hydrolysis but had variable effects on stimulated inositide breakdown. NE-, KCl- and glutamate-stimulated [3H]inositol phosphate release was inhibited by 500 mM ethanol in the cortex. The inhibitory effect of ethanol on NE-stimulated inositide hydrolysis was concentration dependent and significant at concentrations as low as 100 mM. Inhibition by ethanol appeared to be noncompetitive. A similar pattern of inhibition by ethanol was observed when KCl was the stimulant. In hippocampal and hypothalamic slices, similar to cortical slices. NE- and KCl-stimulated inositide breakdown was significantly inhibited by ethanol. However, in brain stem slices, only KCl-stimulated [3H]inositol phosphate release was inhibited. Striatal slices stimulated by carbachol, NE and KCl were sensitive to the inhibitory effects of ethanol on inositol lipid breakdown. These results suggest that ethanol in vitro has specific effects on inositol lipid metabolism depending on the brain region studied and the type of stimulation. Moreover, the differential sensitivity to ethanol of stimulated inositide hydrolysis in the brain may contribute, at least in part, to some of the pharmacological effects of ethanol in vivo.